Clovis Oncology

IPO

Public · Boulder, United States · Founded 2009 · $145.0M raised

Headquarters
Boulder, Colorado
Employees
201–500
Founded
2009
Business Model
B2B
Total Funding
$145.0M
Last Round
$145.0M Series AMay 2009
Rounds
1
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

Clovis Oncology is a commercial-stage biotechnology company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the United States, Europe, and other international markets. The company's approach to precision medicine aims to deliver the right drug to the right patient at the right time, targeting specific subsets of cancer. Clovis develops diagnostic tools in collaboration with partners to direct compounds to patients most likely to benefit.

Summary

Clovis Oncology is a Biotech company based in Boulder, United States, founded in 2009. It has raised $145.0M in total across 1 round, most recently a $145.0M Series A round in May 2009. Investors include Versant Ventures, Domain Associates and Aberdare Ventures.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPONov 2011
$130.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Clovis Oncology on Indexed.vc
<a href="https://indexed.vc/companies/clovis-oncology"><img src="https://indexed.vc/api/badge/company/clovis-oncology" alt="Clovis Oncology on Indexed.vc" width="260" height="76" /></a>